bioXclusters plus has elaborated a series of reports about its strategically defined markets which comprise key country information for successful market entry. In addition, it offers links to documents created by third parties which contain complementary information and data about the countries.
Brazil, a growing and promising health care market
Brazil is the fifth largest country in the world. It has the largest public health system and its pharmaceutical and medical device markets are the most significant in Latin America. Public healthcare is one of the government’s priorities and investments are constantly being sought to modernise deficiencies in health care. In addition, rising incomes with new lifestyle diseases are changing health needs.
Click on the report, published in July 2016, to find out more about Brazil and click here to access more relevant and interesting documentation about this growing and promising market.
You will find bioXclusters resources in our bioXclusters repository section about Brazil, Also our news about this country are listed in our bioXclusters Brazil news category. You will find more information and training materials regarding Brazil at eLSi website.
China, the emerging Asian life sciences giant
Over the last fifteen years, the BRICs have begun to transition from aid-dependent to emerging global actors with significant geopolitical influence.During the 2 last decades, the health sector of the BRICS show double digit growth rate, support by the development of their health system and the development of the local companies.
The Chinese health system is strongly influenced by the communist doctrine and organizes itself around a network of community health centers which provide basic health coverage to the population. Those centers are supposed to dispatch the population to the different hospitals depending on the need of the patient. Unfortunately, the healthcare system has been literally left out by the government during the opening of the economy in the 80s and it is only recently that the government has started to pay more attention to those centers. Today, even with the 2009 health reform, the population still distrust community health center and mostly relied on high level hospitals.
Click here to get the CHINA report, published in July 2017. You will find bioXclusters resources in our website about bioXclusters repository section about CHINA. Also our news about this country are listed in our bioXclusters CHINA news category. You will find more information and training materials regarding CHINA at eLSi website.
Japan, a long term player in Asia Pacific life science market
Japan is the 3rd largest economy in the world with a GDP of 4.383 trillion USD in 20151. Major industries in Japan include manufacturing, construction, services, distribution and communication. The average annual growth since 2012 has been around 1 %, with exports being the main growth driver.
Science and technology research has been fundamental for the Japanese economy. The steadily increasing national research budget acknowledges the importance of research and development (R&D) for the country as well as its role in finding solutions to Japan’s urban, environmental, and economic challenges. Japan is amongst Europe’s top five pharmaceutical trading partners. The national support strategy for industry, science and clusters in pharmaceutical & biotechnology development offers an increasing number of opportunities and incentives for collaborations with international partners.
Click here to get the JAPAN report, published in July 2017. You will find bioXclusters resources in our bioXclusters repository section about JAPAN. Additionally, our news about this country are listed in our bioXclusters Japan news category. You will find more information and training materials regarding Japan at eLSi website
United States of America, the biggest market in healthcare and personalized medicine
The United States, in the 50-year history of the biotechnology industry, has maintained undisputed leadership in the growth of the industry. The country, which is the third largest in volume, is responsible for 70% of the world’s research and development and 86% of its funding (data for 2015); Has developed a strong business structure of 2,175 companies that generated revenues of $ 97.9 billion in 2016, an increase of 2.3% over 2015 and employment of 293,299 people. The average annual salary of workers is above $ 100,000.
Click here to get the USA report, published in July 2017. You will find bioXclusters resources in our website about bioXclusters repository section about USA. Also our news about this country are listed in our bioXclusters USA news category. You will find more information and training materials regarding USA at eLSi website.